CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...
Strongrevenueperformance,includingapproximately$1.9millionmilestoneandlicenserevenuerecognizedin2024Up to $7.5 million in grants awarded from ...
As the Trump administration slashes national environmental regulations and guts key climate programs, the time has come for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback